Found 136 matching trials
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer PHASE2 Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Show More Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Reprab Study: PLD + Trabectedin Rechallenge PHASE2 RECHALLENGE WITH PEGYLATED LIPOSOMAL DOXORUBICIN ADDED TO TRABECTEDIN IN RE...
Show More Location
Fondazione Policlinico Gemelli IRCCS
Learn More & Join Trial
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients PHASE4 This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Show More Learn More & Join Trial
An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) PHASE2 This study is a pilot study of biomarker-driven targeted therapy in patient...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin PHASE1 This is an open-label, single-arm, phase I/II, single-center study with dos...
Show More Location
National University Hospital
Learn More & Join Trial
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma PHASE1 The purpose of this clinical research study is to evaluate the safety and e...
Show More Location
Roy and Patricia Disney Family Cancer Center
Learn More & Join Trial
Metronomic PLD in Patients With Primary Endocrine Resistant ABC PHASE2 Metronomic PLD in Patients with Primary Endocrine Resistant ABC...
Location
Fudan University Cancer Hospital
Learn More & Join Trial
Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC N/A Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and P...
Show More Location
Multiple Locations
Learn More & Join Trial
F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer PHASE3 RATIONALE: F511 cream may prevent or reduce palmar-plantar erythrodysesthes...
Show More Location
Kantonsspital Aarau
Learn More & Join Trial
An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer N/A Clinical trials are, due to the inclusion and exclusion criteria, accomplis...
Show More Location
Praxis und Tagesklinik für gynäkologische Onkologie
Learn More & Join Trial